STAT6 mutations enriched at diffuse large B-cell lymphoma relapse reshape the tumor microenvironment
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
STAT6 mutations enriched at diffuse large B-cell lymphoma relapse reshape the tumor microenvironment ; volume:119 ; number:3 ; day:29 ; month:1 ; year:2024 ; pages:275-290 ; date:3.2024
International journal of hematology ; 119, Heft 3 (29.1.2024), 275-290, 3.2024
- Urheber
-
Benoit, Alexandre
Abraham, Madelyn J.
Li, Sheena
Kim, John
Estrada-Tejedor, Roger
Bakadlag, Rowa
Subramaniam, Nivetha
Makhani, Kiran
Guilbert, Cynthia
Tu, Raymond
Salaciak, Matthew
Klein, Kathleen Oros
Coyle, Krysta Mila
Hilton, Laura K.
Santiago, Raoul
Dmitrienko, Svetlana
Assouline, Sarit
Morin, Ryan D.
del Rincon, Sonia V.
Johnson, Nathalie A.
Mann, Koren K.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s12185-023-03692-x
- URN
-
urn:nbn:de:101:1-2405102101143.787688089248
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:44 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Benoit, Alexandre
- Abraham, Madelyn J.
- Li, Sheena
- Kim, John
- Estrada-Tejedor, Roger
- Bakadlag, Rowa
- Subramaniam, Nivetha
- Makhani, Kiran
- Guilbert, Cynthia
- Tu, Raymond
- Salaciak, Matthew
- Klein, Kathleen Oros
- Coyle, Krysta Mila
- Hilton, Laura K.
- Santiago, Raoul
- Dmitrienko, Svetlana
- Assouline, Sarit
- Morin, Ryan D.
- del Rincon, Sonia V.
- Johnson, Nathalie A.
- Mann, Koren K.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Proteomics uncovers molecular features for relapse risk stratification in patients with diffuse large B-cell lymphoma
Spatial transcriptome of a germinal center plasmablastic burst hints at MYD88/CD79B mutants‐enriched diffuse large B‐cell lymphomas
Personalized Medicine in Diffuse Large B-Cell Lymphoma
Case of Gastric Diffuse Large B-Cell Lymphoma
Diffuse large B-cell lymphoma: An institutional analysis
Molecular Classification of Diffuse Large B-Cell Lymphoma
Characterizing influence of rCHOP treatment on diffuse large B-cell lymphoma microenvironment through in vitro microfluidic spheroid model
Dynamic change of soluble interleukin-2 receptor distinguished molecular heterogeneity and microenvironment alterations in diffuse large B-cell lymphoma
New risk factors and new tendency for central nervous system relapse in patients with diffuse large B-cell lymphoma: a retrospective study
Targeting HDACs for diffuse large B-cell lymphoma therapy
Concurrent Pilomatrix Carcinoma and Diffuse Large B-Cell Lymphoma
Incidence of relapsed/refractory diffuse large B-cell lymphoma (DLBCL) including CNS relapse in a population-based cohort of 4243 patients in Sweden
Proteomics uncovers molecular features for relapse risk stratification in patients with diffuse large B-cell lymphoma
Spatial transcriptome of a germinal center plasmablastic burst hints at MYD88/CD79B mutants‐enriched diffuse large B‐cell lymphomas
Personalized Medicine in Diffuse Large B-Cell Lymphoma
Case of Gastric Diffuse Large B-Cell Lymphoma
Diffuse large B-cell lymphoma: An institutional analysis
Molecular Classification of Diffuse Large B-Cell Lymphoma
Characterizing influence of rCHOP treatment on diffuse large B-cell lymphoma microenvironment through in vitro microfluidic spheroid model
Dynamic change of soluble interleukin-2 receptor distinguished molecular heterogeneity and microenvironment alterations in diffuse large B-cell lymphoma
New risk factors and new tendency for central nervous system relapse in patients with diffuse large B-cell lymphoma: a retrospective study
Targeting HDACs for diffuse large B-cell lymphoma therapy
Concurrent Pilomatrix Carcinoma and Diffuse Large B-Cell Lymphoma
Incidence of relapsed/refractory diffuse large B-cell lymphoma (DLBCL) including CNS relapse in a population-based cohort of 4243 patients in Sweden
Proteomics uncovers molecular features for relapse risk stratification in patients with diffuse large B-cell lymphoma
Spatial transcriptome of a germinal center plasmablastic burst hints at MYD88/CD79B mutants‐enriched diffuse large B‐cell lymphomas
Personalized Medicine in Diffuse Large B-Cell Lymphoma
Case of Gastric Diffuse Large B-Cell Lymphoma
Diffuse large B-cell lymphoma: An institutional analysis
Molecular Classification of Diffuse Large B-Cell Lymphoma
Characterizing influence of rCHOP treatment on diffuse large B-cell lymphoma microenvironment through in vitro microfluidic spheroid model
Dynamic change of soluble interleukin-2 receptor distinguished molecular heterogeneity and microenvironment alterations in diffuse large B-cell lymphoma
New risk factors and new tendency for central nervous system relapse in patients with diffuse large B-cell lymphoma: a retrospective study
Targeting HDACs for diffuse large B-cell lymphoma therapy
Concurrent Pilomatrix Carcinoma and Diffuse Large B-Cell Lymphoma